Study guide

8.4 Risk Assessments for New and Existing Services

Certified Professional in Health Care Risk Management CPHRM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Safety Culture & Event Analysis

1.1 Patient Safety Culture & Just Culture Frameworks 1.2 Incident Reporting, Near-Miss Analysis & Sentinel Events 1.3 Root Cause Analysis (RCA) & Failure Mode Effects Analysis (FMEA) 1.4 Assessing Safety Culture and Staff Awareness 1.5 Corrective Action Plans and Improvement Follow-Up

2 Chapter 2: Safety Education, Engagement & Staff Support

2.1 Designing Risk Management and Patient Safety Education Programs 2.2 Engaging Patients and Families in Reducing Risk 2.3 Tracking National and Local Patient Safety Initiatives 2.4 Critical Incident Debriefing and Second Victim Support

3 Chapter 3: Clinical Risk Consultation & Patient Rights

3.1 Disclosure of Adverse Events & Apology Laws 3.2 Informed Consent, Refusal of Treatment & Advance Directives 3.3 Surrogate Decision Makers and Consent for Minors 3.4 Managing Disruptive Patients, Families, and Visitors 3.5 Release of Information: Subpoenas, Law Enforcement, and Warrants 3.6 Abuse Allegations and Mandatory Reporting Obligations 3.7 Medical Record Documentation Review and Risk Mitigation 3.8 Safe Medication Practices, Infection Control & Diagnostic Safety

4 Chapter 4: Risk Financing & Insurance Principles

4.1 Fundamentals of Healthcare Risk Financing & Exposure Identification 4.2 Commercial Insurance Structures & Coverage Types (Occurrence vs. Claims-Made) 4.3 Alternative Risk Financing: Captives, Risk Retention Groups & Self-Insurance 4.4 Specialty Coverage Lines: D&O, Cyber, Workers' Compensation, and Property 4.5 Program Layering: Retentions, Excess, Umbrella, and Reinsurance

5 Chapter 5: Risk Financing Operations & Contracts

5.1 Actuarial Concepts, Loss Reserving & Retained Risk Calculations 5.2 Contractual Risk Transfer, Indemnification & Hold Harmless Clauses 5.3 Loss Run Analysis and Historical Loss Trending 5.4 Policy Notice Provisions and Timely Reporting Obligations 5.5 Investigating Non-Clinical Accidents and Liability Exposures

6 Chapter 6: Legal Framework & Liability

6.1 Federal Healthcare Statutes: HIPAA/HITECH, EMTALA & PSQIA 6.2 Fraud and Abuse Laws: Stark Law, Anti-Kickback Statute & False Claims Act 6.3 Medical Malpractice Tort Law & Legal Duties of Care 6.4 Involuntary Detention, Psychiatric Holds, and Restraint Law

7 Chapter 7: Regulatory Compliance & Accreditation

7.1 Accreditation Standards: The Joint Commission, CMS & State Licensing 7.2 CMS Conditions of Participation and Deemed Status 7.3 Regulatory Reporting Obligations & Government Investigations 7.4 National Practitioner Data Bank Reporting and Querying 7.5 Safe Medical Device Act, Device Reporting, and Tracking Logs 7.6 Patient Complaints and Grievance Resolution 7.7 The Organizational Compliance Plan and Workforce Compliance 7.8 Bioethics, End-of-Life Care & Ethics Committee Consultation

8 Chapter 8: Risk Management Program Operations

8.1 Enterprise Risk Management (ERM) Frameworks in Healthcare 8.2 Risk Management Program Structure, Governance & Board Reporting 8.3 Policy Development, Clinical Credentialing & Staff Oversight 8.4 Risk Assessments for New and Existing Services 8.5 Supervising and Developing Risk Management Staff 8.6 Annual Risk Program Goals and Measuring Effectiveness

9 Chapter 9: Operational Risk Coordination

9.1 Managing the Disruptive Practitioner and Behavioral Programs 9.2 Committee Support and Enterprise Event Report Management 9.3 Service of Process and Accepting Legal Documents 9.4 Policies for High-Risk Clinical and Operational Domains

10 Chapter 10: Emergency Management, Technology & Environmental Risk

10.1 Healthcare Emergency Preparedness & Business Continuity Planning 10.2 Health IT, Cybersecurity, Telehealth & EHR Risk Management 10.3 Environmental Safety, Medical Equipment & Workplace Violence Prevention

11 Chapter 11: Claims Management

11.1 Potentially Compensable Events (PCEs) & Early Investigation 11.2 Carrier, Broker, and TPA Notification Workflows 11.3 Claims Reserve Establishment & Loss Valuation 11.4 Claim Evaluation, Exposure Analysis, and Resolution Strategy 11.5 Reporting High-Exposure Cases and Aggregate Claims Experience

12 Chapter 12: Litigation Oversight

12.1 Medical Malpractice Litigation Management & Discovery 12.2 Attorney-Client Privilege, Work Product, and Discoverability 12.3 Evidence Preservation, Legal Holds, and Spoliation 12.4 Alternative Dispute Resolution (ADR), Mediation & Settlement Strategy 12.5 Supporting Insured Defendants Through the Litigation Process

8.4 Risk Assessments for New and Existing Services

Key Takeaways Explain This Topic AI

A new service or new technology review must be completed before the first case, covering clinical evidence, privileging criteria, staff competency, equipment, procedure-specific consent, insurance confirmation, regulatory approval, contracts, and post-launch monitoring with predefined stop criteria.

Notifying the broker and carrier of a new service line is a required step, because a new exposure may fall outside the current professional and general liability program or trigger a policy provision requiring notice of a material change in operations.

Inherent risk is scored before controls and residual risk after; boards and executives make accept-or-mitigate decisions on residual risk, and residual risk above the organization's stated tolerance threshold must be escalated rather than accepted locally.

The four risk treatment options are accept, mitigate or reduce, transfer, and avoid; contractual transfer moves financial consequence but does not eliminate liability arising from apparent agency.

In an acquisition, the acquiring organization's occurrence policy does not reach the target's pre-closing incidents, so prior-acts or tail coverage must be confirmed in writing before closing.

Last updated: July 2026

Why Proactive Assessment Sits at the Center of Domain 4

Domain 4, Health Care Operations, contributes 20 scored items to the CPHRM, and task B states it plainly: conduct risk assessments to identify exposures related to new and existing services and enterprise-wide services. Most of the rest of the exam is retrospective — an event happened, a claim arrived, a survey found a deficiency. Risk assessment is the one discipline that runs before harm, and the exam rewards candidates who recognize when a stem is asking for prospective work rather than investigation.

The scope boundary is tested just as hard as the content. The risk manager does not decide whether a service opens. The risk manager convenes the review, identifies exposures, documents them, offers mitigation options, and escalates residual risk that exceeds tolerance to the people who own the decision. Answer choices in which the risk manager "denies privileges," "vetoes the program," or "approves the new laser" exceed the role. Answer choices that say "convene a multidisciplinary review before the first case," "notify the broker of the new exposure," or "document the residual risk and take it to the risk committee" are inside it.

The New Service and New Technology Review

A new service review (also called a new technology or new program assessment) is a structured, multidisciplinary evaluation completed before a service goes live. It is triggered by more than a brand-new service line: a new procedure a surgeon learned at a weekend course, a new device, a new patient population (pediatrics in an adult facility, bariatrics, high-risk obstetrics), a new site of care, a telehealth expansion into another state, an investigational protocol, or a co-management deal with an outside group.

The review should cover, at minimum:

Clinical need and evidence base. Is there demonstrated volume and a body of evidence, or is this a physician-driven request in search of a market? A service with no volume cannot sustain competence.

Credentialing and privileging criteria. Criteria specific to the new procedure — training, case logs, proctoring, and Focused Professional Practice Evaluation (FPPE) — must be written and approved before the first case is scheduled, not retrofitted afterward. (The credentialing process itself is covered in the policy and credentialing section.)

Staff competency and volume thresholds. Nursing, technologists, anesthesia, and perioperative staff need documented training and a competency check-off. Where the literature supports a volume-outcome relationship , set a minimum annual case threshold for both the practitioner and the program.

Equipment, space, and support services. Biomedical acceptance testing, reprocessing and sterilization capability, imaging and blood bank availability, ICU and rapid-response backup, and a written rescue plan for the predictable complication.

Informed consent content. A novel or investigational procedure requires consent language beyond the standard form: the procedure's newness at this facility, the practitioner's experience with it, alternatives including referral elsewhere, any investigational device or Institutional Review Board (IRB) status, and disclosure of financial relationships with the device manufacturer.

Insurance coverage confirmation. This is the step candidates forget. A new service line may fall outside the current professional and general liability program, may require a specific endorsement, or may trigger a policy provision requiring notice of a material change in operations. Notify the broker and carrier in writing and get the confirmation before the first case.

Regulatory and licensure approval. State facility licensure category, certificate of need (CON) where the state requires it, CMS provider-based and enrollment rules, FDA clearance or approval status of the device, IRB approval for research, and state-specific telehealth licensure.

Contract review. Vendor, co-management, and joint venture agreements need indemnification language, insurance requirements with certificates of insurance and additional-insured status, a Business Associate Agreement (BAA) if protected health information moves, and a compliance and counsel review of the financial arrangement.

Policies, protocols, and order sets. Written before go-live, including the escalation and transfer plan.

Post-launch monitoring with predetermined stop criteria. Define the monitoring period, the metrics, the review interval, and — critically — the thresholds that trigger suspension. If leadership cannot state in advance what result would make them stop the program, the assessment is incomplete.

New Service Review Checklist

Review area Core questions Risk management deliverable

Clinical need Is there evidence and projected volume to sustain competence? Written summary of evidence and volume projection

Privileging What criteria, proctoring, and FPPE plan apply? Draft criteria routed to medical staff office and credentials committee

Staff competency Who is trained, and how is competency verified? Competency validation plan with completion dates

Equipment and space Is equipment accepted, reprocessing validated, rescue capability present? Biomedical and infection prevention sign-off

Consent Does the form address novelty, experience, alternatives, and research status? Procedure-specific consent reviewed by counsel

Insurance Is the exposure covered, and does the carrier need notice? Written broker and carrier confirmation or endorsement

Regulatory Licensure, CON, CMS enrollment, FDA status, IRB approval? Regulatory clearance file

Contracts Indemnification, insurance requirements, BAA, compliance review? Executed agreement with risk-transfer terms

Monitoring What is measured, how often, and what stops the program? Monitoring plan with predefined stop criteria